H.I.G. Capital Acquires BioVectra Inc.
November 4, 2019
H.I.G. Capital, through an affiliate, completed the acquisition of BioVectra Inc., a Canadian contract development and manufacturing organization (CDMO) specializing in active pharmaceutical ingredients (APIs), intermediates and biologics. The deal — a carve-out from Mallinckrodt — positions H.I.G. to support BioVectra's growth and further expand its manufacturing capabilities across Charlottetown, Prince Edward Island and Windsor, Nova Scotia.
- Buyers
- H.I.G. Capital
- Targets
- BioVectra Inc.
- Sellers
- Mallinckrodt plc
- Industry
- Pharmaceuticals
- Location
- Prince Edward Island, Canada
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.